Patents by Inventor Jim Vadolas

Jim Vadolas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treatment
    Patent number: 11046956
    Abstract: The present disclosure teaches the treatment of a blood pathology, such as a blood pathology associated with impaired hemoglobin synthesis including the treatment of ?-thalassemia or a related hemoglobinopathy.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: June 29, 2021
    Assignee: Hudson Institute of Medical Research
    Inventor: Jim Vadolas
  • METHOD OF TREATMENT
    Publication number: 20190300881
    Abstract: The present disclosure teaches the treatment of a blood pathology, such as a blood pathology associated with impaired hemoglobin synthesis including the treatment of ?-thalassemia or a related hemoglobinopathy.
    Type: Application
    Filed: April 9, 2019
    Publication date: October 3, 2019
    Inventor: Jim VADOLAS
  • Method of treatment
    Patent number: 10301620
    Abstract: The present disclosure teaches the treatment of a blood pathology, such as a blood pathology associated with impaired hemoglobin synthesis including the treatment of ?-thalassemia or a related hemoglobinopathy. An RNA molecule such as a short interfering RNA or a hairpin RNA which targets an mRNA species encoding ?-globin is administered to a subject to reduce the amount of ?-globin produced to non-zero levels and ameliorate the effects of an ?- and ?-globin chain imbalance.
    Type: Grant
    Filed: December 20, 2011
    Date of Patent: May 28, 2019
    Assignee: MURDOCH CHILDRENS RESEARCH INSTITUTE
    Inventor: Jim Vadolas
  • METHOD OF TREATMENT
    Publication number: 20140031412
    Abstract: The present disclosure teaches the treatment of a blood pathology, such as a blood pathology associated with impaired hemoglobin synthesis including the treatment of ?-thalassemia or a related hemoglobinopathy. An RNA molecule such as a short interfering RNA or a hairpin RNA which targets an mRNA species encoding ?-globin is administered to a subject to reduce the amount of ?-globin produced to non-zero levels and ameliorate the effects of an ?- and ?-globin chain imbalance.
    Type: Application
    Filed: December 20, 2011
    Publication date: January 30, 2014
    Applicant: MURDOCH CHILDENS RESEARCH INSTITUTE
    Inventor: Jim Vadolas